Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 702 | $427,152,584 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,191.02 | 4,764 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 1 | 1,190 | 1,190 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 5 | 1,189.13 | 5,946 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,188.55 | 4,754 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 3 | 1,187.95 | 3,564 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,185.77 | 4,743 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 5 | 1,186.19 | 5,931 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 1 | 1,184.26 | 1,184 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 8 | 1,183.47 | 9,468 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,178.69 | 4,715 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 8 | 1,179.62 | 9,437 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,177.73 | 4,711 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,176.82 | 4,707 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 8 | 1,175.66 | 9,405 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 8 | 1,174.32 | 9,395 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 16 | 1,172.75 | 18,764 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,170.4 | 4,682 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,166.52 | 4,666 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 1 | 1,167.27 | 1,167 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Sep 2024 | Sale | 4 | 1,168.99 | 4,676 | D |
05 Sep 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Sep 2024 | Sale | 1,000 | 1,178.73 | 1,178,730 | D |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 200 | 1,206.67 | 241,334 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 235 | 1,205.67 | 283,332 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 200 | 1,206.7 | 241,340 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 236 | 1,205.67 | 284,538 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 450 | 1,206.15 | 542,768 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 928 | 1,205.49 | 1,118,695 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 2,237 | 1,204.71 | 2,694,936 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 200 | 1,206.3 | 241,260 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 766 | 1,205.44 | 923,367 | I |
29 Aug 2024 16:27 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 28 Aug 2024 | Sale | 228 | 1,204.79 | 274,692 | I |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 100 | 1,161.32 | 116,132 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 234 | 1,160.45 | 271,545 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 5,352 | 1,159.56 | 6,205,965 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 212 | 1,158.02 | 245,500 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 1,560 | 1,157.33 | 1,805,435 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 2,368 | 1,156.3 | 2,738,118 | D |
19 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 15 Aug 2024 | Sale | 1,012 | 1,155.72 | 1,169,589 | D |
19 Aug 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 15 Aug 2024 | Sale | 756 | 1,170 | 884,520 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 331 | 1,159.69 | 383,857 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 189 | 1,158.78 | 219,009 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 178 | 1,157.41 | 206,019 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 1,016 | 1,156.43 | 1,174,933 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 402 | 1,155.76 | 464,616 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 987 | 1,153.74 | 1,138,741 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 777 | 1,154.66 | 897,171 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 197 | 1,152.36 | 227,015 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 185 | 1,151.46 | 213,020 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 844 | 1,150.41 | 970,946 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 294 | 1,149.6 | 337,982 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 537 | 1,148.52 | 616,755 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 51 | 1,146.6 | 58,477 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 148 | 1,145.58 | 169,546 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 45 | 1,144.89 | 51,520 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 79 | 1,143.28 | 90,319 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 48 | 1,142.94 | 54,861 | D |
15 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Aug 2024 | Sale | 55 | 1,140.31 | 62,717 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 300 | 1,086.15 | 325,845 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 1,708 | 1,085.01 | 1,853,197 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 1,883 | 1,084.61 | 2,042,321 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 1,006 | 1,083.76 | 1,090,263 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 200 | 1,082.69 | 216,538 | D |
12 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 08 Aug 2024 | Sale | 100 | 1,081.83 | 108,183 | D |
07 Aug 2024 16:40 | REGN | REGENERON PHARMACEUTICALS Inc | PITOFSKY JASON | VP Controller | 07 Aug 2024 | Sale | 487 | 1,070 | 521,090 | D |
05 Aug 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 02 Aug 2024 | Sale | 756 | 1,115 | 842,940 | D |
05 Aug 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2024 | Sale | 1,137 | 1,060.86 | 1,206,198 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,099.65 | 3,299 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,098 | 1,098 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,097.69 | 3,293 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,096.19 | 3,289 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,095.35 | 3,286 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,094.02 | 1,094 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 7 | 1,093.39 | 7,654 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 7 | 1,092.61 | 7,648 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 13 | 1,091.47 | 14,189 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 11 | 1,090.3 | 11,993 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,088.7 | 3,266 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 7 | 1,089.64 | 7,627 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 2 | 1,087.54 | 2,175 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 2 | 1,086.38 | 2,173 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,084.71 | 3,254 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,085.71 | 3,257 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,083.57 | 1,084 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,082.17 | 1,082 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 3 | 1,076.07 | 3,228 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,080.06 | 1,080 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,074.34 | 1,074 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,073.03 | 1,073 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 4 | 1,070.46 | 4,282 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,068.08 | 1,068 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,067.53 | 1,068 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 4 | 1,066.33 | 4,265 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 6 | 1,065.39 | 6,392 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,062.71 | 1,063 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,058.9 | 1,059 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,053.22 | 1,053 | D |
05 Aug 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2024 | Sale | 1 | 1,100.03 | 1,100 | D |
12 Jul 2024 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 11 Jul 2024 | Sale | 1,866 | 1,088.95 | 2,031,981 | D |
02 Jul 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jul 2024 | Sale | 3 | 1,067.51 | 3,203 | D |
02 Jul 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jul 2024 | Sale | 2 | 1,068.09 | 2,136 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)